siRNA, Anti-Human ADRA2B, LNA(CAT#: SIRGT04100WQ-LNA)

The product SIRGT04100WQ-LNA is a type of small interfering RNA (siRNA) that targets ADRA2B gene and regulates the expression of gene. The siRNA interferes with the expression of ADRA2B gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is systematically modified with the synthetic RNA-like high affinity nucleotide analogue, Locked Nucleic Acid (LNA), to improve its bio-stability, specificity and efficiency. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
Modification Locked Nucleic Acid (LNA)
Scale 20/50/100/200 nmole
NCBI RefSeq NM_000682.6
Alternative Names ADRA2L1; ADRA2RL1; ADRARL1; ALPHA2BAR; FAME2; alpha-2BAR
Related Diseases Benign Adult Familial Myoclonic Epilepsy, Epilepsy
Purification HPLC
Target Gene
Gene ID 151
Uniprot ID P18089

Related Products